# Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Acid Metabolism?

> **NCT01577004** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 fatty acid

## Key facts

- **NCT ID:** NCT01577004
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01577004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01577004, "Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Acid Metabolism?". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01577004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*